124 related articles for article (PubMed ID: 3321268)
21. Gram-negative bacterial resistance: evolving patterns and treatment paradigms.
Kollef MH
Clin Infect Dis; 2005 Feb; 40 Suppl 2():S85-8. PubMed ID: 15712101
[TBL] [Abstract][Full Text] [Related]
22. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
[TBL] [Abstract][Full Text] [Related]
23. Nosocomial bacterial pneumonias.
Septimus EJ
Semin Respir Infect; 1989 Dec; 4(4):245-52. PubMed ID: 2697049
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
[TBL] [Abstract][Full Text] [Related]
26. Selective decontamination of the digestive tract: risks outweigh benefits for intensive care unit patients.
Duncan RA; Steger KA; Craven DE
Semin Respir Infect; 1993 Dec; 8(4):308-24. PubMed ID: 7938928
[TBL] [Abstract][Full Text] [Related]
27. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention.
Safdar N; Crnich CJ; Maki DG
Respir Care; 2005 Jun; 50(6):725-39; discussion 739-41. PubMed ID: 15913465
[TBL] [Abstract][Full Text] [Related]
28. [Review of oral cephalosporins. Basis for a rational choice].
Forti IN
Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
[TBL] [Abstract][Full Text] [Related]
29. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems.
Kollef MH
Respir Care; 2004 Dec; 49(12):1530-41. PubMed ID: 15571647
[TBL] [Abstract][Full Text] [Related]
30. Control of infections caused by drug-resistant organisms in critical care.
Hoppe B
Am J Crit Care; 1997 Mar; 6(2):141-4. PubMed ID: 9172851
[TBL] [Abstract][Full Text] [Related]
31. Advances in antibacterial therapy against emerging bacterial pathogens.
Pournaras S; Iosifidis E; Roilides E
Semin Hematol; 2009 Jul; 46(3):198-211. PubMed ID: 19549574
[TBL] [Abstract][Full Text] [Related]
32. Nursing home-acquired pneumonia.
El Solh AA
Semin Respir Crit Care Med; 2009 Feb; 30(1):16-25. PubMed ID: 19199183
[TBL] [Abstract][Full Text] [Related]
33. Pneumonia in the elderly.
Niederman MS; Fein AM
Clin Geriatr Med; 1986 May; 2(2):241-68. PubMed ID: 3516364
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
35. Advances in the management of pneumonia in the intensive care unit: review of current thinking.
Rello J; Diaz E; Rodríguez A
Clin Microbiol Infect; 2005 Oct; 11 Suppl 5():30-8. PubMed ID: 16138817
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
Rhomberg PR; Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):57-62. PubMed ID: 16631338
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and treatment of community-acquired and hospital-acquired pneumonia.
Foster MT
Pharmacotherapy; 1993; 13(2 Pt 2):45S-50S. PubMed ID: 8474938
[TBL] [Abstract][Full Text] [Related]
38. Monotherapy versus combination antimicrobial therapy: a review.
Barriere SL
Pharmacotherapy; 1991; 11(2 ( Pt 2)):64S-71S. PubMed ID: 2041834
[TBL] [Abstract][Full Text] [Related]
39. [Selective digestive decontamination. An entity to be defined].
León Gil C
Enferm Infecc Microbiol Clin; 1991 Feb; 9(2):72-5. PubMed ID: 1854853
[No Abstract] [Full Text] [Related]
40. Bacterial pneumonia in the HIV-infected patient.
Cohn DL
Infect Dis Clin North Am; 1991 Sep; 5(3):485-507. PubMed ID: 1955696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
